Related references
Note: Only part of the references are listed.No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis
Katharina Bluemlein et al.
Oncotarget (2015)
Regulation of ADAM10 and ADAM17 by Sorafenib Inhibits Epithelial-to-Mesenchymal Transition in Epstein-Barr Virus-Infected Retinal Pigment Epithelial Cells
Ga Bin Park et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2015)
Autocrine galectin-1 promotes collective cell migration of squamous cell carcinoma cells through up-regulation of distinct integrins
Andra Rizqiawan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
ADAM17 Mediates MMP9 Expression in Lung Epithelial Cells
Ya-qing Li et al.
PLOS ONE (2013)
Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production
X. Yuan et al.
CELL DEATH & DISEASE (2013)
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dianne H. Dapito et al.
CANCER CELL (2012)
Galectin-1 Promotes Lung Cancer Progression and Chemoresistance by Upregulating p38 MAPK, ERK, and Cyclooxygenase-2
Ling-Yen Chung et al.
CLINICAL CANCER RESEARCH (2012)
Toll-like receptor genes and their association with colon and rectal cancer development and prognosis
Martha L. Slattery et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Pyruvate kinase type M2 is upregulated in colorectal cancer and promotes proliferation and migration of colon cancer cells
Cheng-Fu Zhou et al.
IUBMB LIFE (2012)
Lactate: A Metabolic Key Player in Cancer
Franziska Hirschhaeuser et al.
CANCER RESEARCH (2011)
ADAM-17 over-expression in gallbladder carcinoma correlates with poor prognosis of patients
Kai Wu et al.
MEDICAL ONCOLOGY (2011)
Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation
Connie M. Krawczyk et al.
BLOOD (2010)
High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer
E. L. Wang et al.
BRITISH JOURNAL OF CANCER (2010)
Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
Victor L. Thijssen et al.
CANCER RESEARCH (2010)
Human pyruvate kinase M2: A multifunctional protein
Vibhor Gupta et al.
PROTEIN SCIENCE (2010)
The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes
Arnold J. Levine et al.
SCIENCE (2010)
Reduced c-myc Expression Levels Limit Follicular Mature B Cell Cycling in Response to TLR Signals
Almut Meyer-Bahlburg et al.
JOURNAL OF IMMUNOLOGY (2009)
Galectin-1-Mediated Tumor Invasion and Metastasis, Up-Regulated Matrix Metalloproteinase Expression, and Reorganized Actin Cytoskeletons
Ming-Heng Wu et al.
MOLECULAR CANCER RESEARCH (2009)
Toll-like receptors and cancer
Seth Rakoff-Nahoum et al.
NATURE REVIEWS CANCER (2009)
Is cancer a disease of abnormal cellular metabolism? New angles on an old idea
Ralph J. DeBerardinis
GENETICS IN MEDICINE (2008)
The ADAM metalloproteinases
Dylan R. Edwards et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Role of Toll-like receptors in gastrointestinal malignancies
M. Fukata et al.
ONCOGENE (2008)
Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells
S. H. Hsieh et al.
ONCOGENE (2008)
TLR signaling by tumor and immune cells: a double-edged sword
B. Huang et al.
ONCOGENE (2008)
The toll-like receptor pathway: A novel mechanism of infection-induced carcinogenesis of prostate epithelial cells
Shilajit D. Kundu et al.
PROSTATE (2008)
Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer
Eun-Jung Jung et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Lactate stimulates endothelial cell migration
Stefan Beckert et al.
WOUND REPAIR AND REGENERATION (2006)
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer
MG Kelly et al.
CANCER RESEARCH (2006)
Galectin-1: A link between tumor hypoxia and tumor immune privilege
QT Le et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Galectin-1 interacts with the α5β1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27
C Fischer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Pyruvate kinase type M2 and its role in tumor growth and spreading
S Mazurek et al.
SEMINARS IN CANCER BIOLOGY (2005)
Toll-like receptors on tumor cells facilitate evasion of immune surveillance (Publication with Expression of Concern. See vol. 79, pg. 4305, 2019)
B Huang et al.
CANCER RESEARCH (2005)
Galectins as modulators of tumour progression
FT Liu et al.
NATURE REVIEWS CANCER (2005)
Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression
JL Luo et al.
CANCER CELL (2004)
Lactate: Mirror and motor of tumor malignancy
S Walenta et al.
SEMINARS IN RADIATION ONCOLOGY (2004)
Evaluation of MYC E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays
JW Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting
N Nagy et al.
CANCER (2003)
Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin
F van den Brûle et al.
LABORATORY INVESTIGATION (2003)
Upregulation of galectins-1 and-3 in human colon cancer and their role in regulating cell migration
A Hittelet et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Endotoxin/lipopolysaccharide activates NF-κB and enhances tumor cell adhesion and invasion through a β1 integrin-dependent mechanism
JH Wang et al.
JOURNAL OF IMMUNOLOGY (2003)
Tumor cell adhesion to endothelial cells is increased by endotoxin via an upregulation of β-1 integrin expression
EJ Andrews et al.
JOURNAL OF SURGICAL RESEARCH (2001)
Share Paper
